# Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye

> **NCT03436576** · PHASE3 · UNKNOWN · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 20 (estimated)

## Conditions studied

- Dry Eye
- Keratoconjunctivitis Sicca
- Sjogren's Syndrome
- Corneal Diseases
- Conjunctival Diseases
- Keratitis
- Lacrimal Apparatus Diseases

## Interventions

- **DRUG:** Autologous Serum 20%
- **DRUG:** Autologous Serum 50%

## Key facts

- **NCT ID:** NCT03436576
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-12
- **Primary completion:** 2018-10-19
- **Final completion:** 2018-11-19
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03436576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03436576, "Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03436576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*